IART

Integra LifeSciences Holdings CorporationNASDAQHealthcare

$9.53-0.42%ClosedMarket Cap: $742.7M

As of 2026-04-06

Valuation

P/E (TTM)

—

PEG

—

P/B

0.68

P/S

0.44

EV/EBITDA

-7.74

DCF Value

$73.71

FCF Yield

-8.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

51.7%

Operating Margin

4.2%

Net Margin

-31.6%

ROE

-44.5%

ROA

-14.3%

ROIC

1.9%

Income Statement

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q4 2025	$434.9M	49.5%	$556.2M	$-1.7M	$-0.02	—
FY 2025	$1.64B	51.7%	$68.3M	$-516.5M	$-6.73	—
Q3 2025	$402.1M	56.2%	$40.3M	$-5.4M	$-0.07	—
Q2 2025	$415.6M	50.4%	$-512.7M	$-484.1M	$-6.33	—
Q1 2025	$382.7M	50.8%	$-15.5M	$-25.3M	$-0.33	—
Q4 2024	$442.6M	56.3%	$35.6M	$19.4M	$0.25	—
FY 2024	$1.61B	54.8%	$28.4M	$-6.9M	$-0.09	—
Q3 2024	$380.8M	52.6%	$-8.2M	$-10.7M	$-0.14	—
Q2 2024	$418.2M	54.0%	$-3.0M	$-12.4M	$-0.16	—
Q1 2024	$368.9M	56.1%	$4.0M	$-3.3M	$-0.04	—
Q4 2023	$397.0M	57.0%	$36.0M	$19.8M	$0.25	—
FY 2023	$1.54B	57.4%	$111.5M	$67.7M	$0.84	—